Mitchell Sinkler & Starr PA Purchases 542 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

Mitchell Sinkler & Starr PA increased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 33.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,170 shares of the exchange traded fund’s stock after buying an additional 542 shares during the period. Mitchell Sinkler & Starr PA’s holdings in SPDR S&P Biotech ETF were worth $212,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of XBI. HBK Sorce Advisory LLC raised its stake in SPDR S&P Biotech ETF by 2.6% during the 1st quarter. HBK Sorce Advisory LLC now owns 4,538 shares of the exchange traded fund’s stock valued at $431,000 after purchasing an additional 113 shares during the last quarter. Intellectus Partners LLC raised its stake in SPDR S&P Biotech ETF by 1.0% during the 2nd quarter. Intellectus Partners LLC now owns 11,334 shares of the exchange traded fund’s stock valued at $1,051,000 after purchasing an additional 113 shares during the last quarter. Concourse Financial Group Securities Inc. raised its stake in SPDR S&P Biotech ETF by 21.2% during the 4th quarter. Concourse Financial Group Securities Inc. now owns 658 shares of the exchange traded fund’s stock valued at $59,000 after purchasing an additional 115 shares during the last quarter. Pacific Center for Financial Services raised its stake in SPDR S&P Biotech ETF by 2.8% during the 1st quarter. Pacific Center for Financial Services now owns 4,359 shares of the exchange traded fund’s stock valued at $414,000 after purchasing an additional 118 shares during the last quarter. Finally, Kingsview Wealth Management LLC raised its stake in SPDR S&P Biotech ETF by 3.8% during the 1st quarter. Kingsview Wealth Management LLC now owns 3,495 shares of the exchange traded fund’s stock valued at $332,000 after purchasing an additional 127 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

NYSEARCA:XBI opened at $98.90 on Thursday. The stock has a market cap of $7.54 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The company has a fifty day moving average price of $98.13 and a 200 day moving average price of $93.91.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.